The Telehealth Enhancement of Adherence to Medication (TEAM) in pediatric IBD trial: Design and methodology
| Autor: | Michele H Maddux, Kevin A. Hommel, Katherine Loreaux, Wendy N. Gray, Lee A. Denson, Robert N. Baldassano, Francisco A. Sylvester, David J. Keljo, Elizabeth A. Hente, Charles R. Doarn, Wallace Crandall, Richard F. Ittenbach, Melvin B. Heyman |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Male
Research design Telemedicine medicine.medical_specialty Adolescent Reminder Systems Medication adherence Telehealth Severity of Illness Index Article Medication Adherence Quality of life (healthcare) Patient Education as Topic Intervention (counseling) Severity of illness Health care Humans Medicine Pharmacology (medical) Child Internet business.industry General Medicine Health Services Inflammatory Bowel Diseases Telephone Self Care Research Design Quality of Life Physical therapy Female business |
| Zdroj: | Contemporary Clinical Trials. 43:105-113 |
| ISSN: | 1551-7144 |
| Popis: | Medication nonadherence is a significant health care issue requiring regular behavioral treatment. Lack of sufficient health care resources and patient/family time commitment for weekly treatment are primary barriers to receiving appropriate self-management support. We describe the methodology of the Telehealth Enhancement of Adherence to Medication (TEAM) trial for medication nonadherence in pediatric inflammatory bowel disease (IBD). For this trial, participants 11-18 years of age will be recruited from seven pediatric hospitals and will complete an initial 4-week run in to assess adherence to a daily medication. Those who take less than 90% of their prescribed medication will be randomized. A total of 194 patients with IBD will be randomized to either a telehealth behavioral treatment (TBT) arm or education only (EO) arm. All treatments will be delivered via telehealth video conferencing. The patients will be assessed at baseline, post-treatment, 3, 6, and 12 months. We anticipate that participants in the TBT arm will demonstrate a statistically significant improvement at post-treatment and 3-, 6-, and 12-month follow-up compared to participants in the EO arm for both medication adherence and secondary outcomes (i.e., disease severity, patient quality of life, and health care utilization). If efficacious, the TEAM intervention could be disseminated broadly and reduce health care access barriers so that the patients could receive much needed self-management intervention. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect